STEMI Mimic: Focal Myocarditis in an Adolescent Patient After mRNA COVID-19 Vaccine

Background: In May 2021, the U.S. Food and Drug Administration expanded the Emergency Use Authorization for the Pfizer-BioNTech mRNA Coronavirus disease 2019 (COVID-19) Vaccine (BNT162b2) to include adolescents 12–15 years of age. As vaccine administration continues to increase, potential adverse ou...

Descripción completa

Detalles Bibliográficos
Autores principales: Azir, Michael, Inman, Brannon, Webb, James, Tannenbaum, Lloyd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Communications: Adult
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469220/
https://www.ncbi.nlm.nih.gov/pubmed/34756746
http://dx.doi.org/10.1016/j.jemermed.2021.09.017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8469220/
https://www.ncbi.nlm.nih.gov/pubmed/34756746
http://dx.doi.org/10.1016/j.jemermed.2021.09.017

Ejemplares similares